• Home /Exam Details (QP Included) / Bharati Biotech finishes oral cholera vaccine trials
  • Bharati Biotech finishes oral cholera vaccine trials
    Posted on May 22nd, 2025 in Exam Details (QP Included)

    • Hillchol, an oral cholera vaccine, has completed phase III clinical trials.

    • The trial evaluated safety, immunogenicity, non-inferiority, and consistency of Hillchol’s single component compared to a comparator vaccine.

    • The trial involved 1,800 individuals across 10 clinical sites in India.

    • Hillchol showed a 4-fold increase in vibriocidal antibodies against Ogawa and Inaba serotypes, proving non-inferiority to licensed vaccines.

    • The trials will lead to Hillchol’s distribution in the next few months.

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

     WBCS Foundation Course Classroom Online 2024 2025 WBCS Preliminary Exam Mock Test WBCS Main Exam Mock Test WBCS Main Language Bengali English Nepali Hindi Descriptive Paper